FMC
About: FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Employees: 5,700
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
33% more repeat investments, than reductions
Existing positions increased: 206 | Existing positions reduced: 155
13% more call options, than puts
Call options by funds: $137M | Put options by funds: $121M
2.93% less ownership
Funds ownership: 92.04% [Q4 2024] → 89.11% (-2.93%) [Q1 2025]
12% less funds holding
Funds holding: 587 [Q4 2024] → 519 (-68) [Q1 2025]
15% less capital invested
Capital invested by funds: $5.59B [Q4 2024] → $4.74B (-$845M) [Q1 2025]
36% less first-time investments, than exits
New positions opened: 97 | Existing positions closed: 151
67% less funds holding in top 10
Funds holding in top 10: 6 [Q4 2024] → 2 (-4) [Q1 2025]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$45
6%
upside
Avg. target
$49
15%
upside
High target
$53
25%
upside
5 analyst ratings
3 positive
60%
2 neutral
40%
0 negative
0%
RBC Capital Arun Viswanathan | 11%upside $47 | Sector Perform Maintained | 10 Jul 2025 |
UBS Joshua Spector | 6%upside $45 | Neutral Maintained | 9 Jul 2025 |
Barclays Benjamin Theurer | 16%upside $49 | Overweight Maintained | 7 Jul 2025 |
Wells Fargo Richard Garchitorena | 18%upside $50 | Overweight Upgraded | 23 Jun 2025 |
Keybanc Aleksey Yefremov | 25%upside $53 | Overweight Maintained | 2 May 2025 |
Financial journalist opinion
Based on 11 articles about FMC published over the past 30 days
Neutral
GlobeNewsWire
4 days ago
FMC ALERT: Bragar Eagel & Squire, P.C. is Investigating FMC Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FMC Corporation (NYSE:FMC) on behalf of long-term stockholders following a class action complaint that was filed against FMC on May 29, 2025 with a Class Period from November 16, 2023 to February 4, 2025. Our investigation concerns whether the board of directors of FMC have breached their fiduciary duties to the company.
Positive
Zacks Investment Research
4 days ago
FMC or CTVA: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Agriculture - Operations sector have probably already heard of FMC (FMC) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?
Positive
Zacks Investment Research
1 week ago
Will FMC (FMC) Beat Estimates Again in Its Next Earnings Report?
FMC (FMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Neutral
Zacks Investment Research
1 week ago
FMC's Tremisia Fungicide Debuts in EMEA Region After Approvals
FMC launches Tremisia fungicide in Ukraine, bringing fluindapyr tech to EMEA growers battling major crop diseases.
Neutral
PRNewsWire
1 week ago
FMC Corporation expands novel fluindapyr fungicide technology to EMEA region
Tremisia® fungicide receives registration in Ukraine, bringing growers a new tool to combat challenging crop diseases PHILADELPHIA , June 30, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.
Neutral
Seeking Alpha
2 weeks ago
Hold On To FMC Corporation (Rating Downgrade)
We assess FMC Corporation as a Hold to moderate buy, downgrading from a previous buy opportunity due to weak growth, momentum, and financial potential. FMC's strengths are its innovation, R&D focus, and attractive 5.4% dividend yield, but revenue and profit have declined for several years. FMC valuation is fair around $50 per share, but insider and hedge fund selling, high debt, and weak near-term growth limit upside.
Neutral
PRNewsWire
3 weeks ago
FMC Corporation announces date for second quarter 2025 earnings release and webcast conference call
PHILADELPHIA , June 19, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its second quarter 2025 earnings on Wednesday, July 30, 2025, after the stock market close via PR Newswire and the company's website https://investors.fmc.com. The company will host a webcast conference call on Thursday, July 31, 2025, at 9:00 a.m.
Neutral
GlobeNewsWire
3 weeks ago
FMC ALERT: Bragar Eagel & Squire, P.C. is Investigating FMC Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FMC Corporation (NYSE:FMC) on behalf of long-term stockholders following a class action complaint that was filed against FMC on February 13, 2025 with a Class Period from November 16, 2023 to February 4, 2025.
Neutral
Accesswire
3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against FMC Corporation (FMC) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FMC Corporation ("FMC" or "the Company") (NYSE:FMC). Investors who purchased FMC securities prior to November 16, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FMC.
Neutral
Accesswire
3 weeks ago
FMC Corporation (FMC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FMC Corporation ("FMC" or "the Company") (NYSE:FMC). Investors who purchased FMC securities prior to November 16, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FMC.
Charts implemented using Lightweight Charts™